FDA chief seeks new powers to police pharmacies

(AP)—The country's top medical regulator is preparing to tell Congress that new laws are needed to police large specialty pharmacies like the one at the center of a deadly meningitis outbreak.

Testimony released ahead of the first congressional hearing on the incident shows that Commissioner Margaret Hamburg will ask to give her agency more authority and funding to oversee compounding pharmacies. She plans to testify before the House Energy and Commerce Committee.

About 440 people have been sickened by contaminated steroid shots distributed by New England Compounding Center, and more than 32 deaths have been reported. Congress is meeting to consider new restrictions on compounding pharmacies, which currently operate in a legal gray area between state and federal regulation.

0 shares

Related Stories

FDA chief will testify at first meningitis hearing

date Nov 05, 2012

(AP)—House lawmakers investigating a nationwide outbreak of deadly meningitis are asking the head of the Food and Drug Administration to testify at the first congressional hearing on the issue next week.

US clinics rush to warn of tainted steroid; 5 dead

date Oct 05, 2012

(AP)—Health providers scrambled to notify patients in nearly two dozen U.S. states that the steroid injections they received for back pain may have been contaminated with a deadly fungal meningitis. Five ...

Recommended for you

Score IDs patients with upper extremity DVT at low risk

date 11 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date 21 hours ago

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date 21 hours ago

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.